General anaesthesia carries its own risks, including reactions to medicines and breathing or heart problems. The anaesthetist will assess these risks before surgery.
Blood clots can form in the deep veins of the legs (deep vein thrombosis) and may travel to the lungs (pulmonary embolism), which can be life-threatening. Measures to reduce this risk are planned according to individual risk.
Pain or discomfort in the breasts, chest or around the scars usually improves as healing progresses, but it may persist for several months and, in some patients, may be long-term.
Previous surgery can affect the blood supply to the breast skin, fat, nipple and areola. If the blood supply is reduced, areas of skin or breast tissue, or part or all of the nipple and areola, may heal poorly or not survive. This may require prolonged wound care or further surgery. The risk may be higher when the tissues are thin, when a breast lift is combined with implant surgery, or in patients who smoke or have certain medical conditions.
Additional risks depend on the techniques included in your revision. Releasing or removing the capsule can increase the risk of bleeding and fluid collection; because the capsule can sit against the chest wall, removing it may rarely injure the chest wall or lung lining (pneumothorax). A breast lift creates additional scars and can cause wound breakdown, changes in nipple sensation, reduced ability to breastfeed and partial or complete loss of the nipple and areola. With fat transfer, not all transferred fat survives, which can cause firm lumps (fat necrosis), oil cysts or calcification that may need breast imaging or further assessment, and additional treatment may be needed to reach the planned volume.
Replacement implants, like all breast implants, are not lifetime devices. There is no fixed replacement date, but you will likely need further surgery to revise, replace, or remove the implants at some stage. Ongoing breast checks and any recommended imaging remain important after revision surgery.
Implant-related complications can also occur after revision surgery. The implant shell can rupture, which may cause no symptoms and may only be found on breast imaging. Capsular contracture can recur even after treatment, causing firmness, discomfort, or a change in breast shape. The implant can move from its intended position, sitting too low, too far to the side or towards the centre of the chest. If the skin or tissue covering the implant breaks down, the implant can become exposed, which usually requires further surgery and may require implant removal.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer of the immune system that can develop in the fluid or scar tissue around a breast implant. It is not a cancer of the breast tissue itself. BIA-ALCL has been associated mainly with textured implants and most often appears years after surgery as new swelling or a lump in the breast. When diagnosed early, doctors usually treat it by removing the implant and the surrounding capsule.
Other rare cancers, including squamous cell carcinoma and other lymphomas, have also been reported in the capsule around breast implants. If you notice new swelling, a lump, pain or any other change in the breast at any time after implant surgery, contact Dr Barker or your general practitioner for assessment.
The risks relevant to your proposed operation will be discussed during consultation and through the formal informed-consent process.